Search for: "Lange v. United States"
Results 1 - 20
of 285
Sort by Relevance
|
Sort by Date
1 Nov 2024, 11:40 am
Add to this the fact that the United States Patent and Trademark Office never requires the description to be adapted, yet patent enforcement obviously works there as well, and you may arrive at the conclusion that there is certainly no “business case” for the adaptation of a description if the claims are amended. [read post]
23 Sep 2024, 8:02 am
Teva Santé et al, No. 12/07203), while a few months later the Paris High Court rejected patentability for successive daily dosage units for administering the active ingredient desogestrel, on the grounds that this was a therapeutic method excluded from patentability (Paris High Court, 5 December 2014, Akzo Nobel NV et al. v. [read post]
12 Sep 2024, 2:15 am
In this case, Scandit argued that (unlike the 10x Genomics case) proceedings for the recognition and enforcement in the United States of America of a foreign damages award would result in considerable legal costs which, even if successful, would not have to be reimbursed by the debtor. [read post]
9 Sep 2024, 12:39 pm
Co-authored by Dara Offrede The first Over-the-Counter Continuous Glucose Monitor (CGM) ever cleared in the United Stated by the FDA was launched by Dexcom. [read post]
24 Jul 2024, 4:35 am
Eventually, UPC establishes a much higher threshold of antibodies patentability in Europe than in the United States. [read post]
24 Jul 2024, 4:35 am
Eventually, UPC establishes a much higher threshold of antibodies patentability in Europe than in the United States. [read post]
18 Jul 2024, 7:59 am
" State ex rel. [read post]
9 Jul 2024, 11:28 am
Regulatory hegemony becomes important in that context, and hegemony for the purpose of preserving the solidity and position of States within complex clusters of human collectives may be served virtually through regulation platforms that serve as a united front. [read post]
9 Jul 2024, 4:10 am
This follows his earlier judgment in Teva v Novartis ([2022] EWHC 2847 (Pat)). [read post]
28 Jun 2024, 8:40 am
United States. [read post]
25 Jun 2024, 11:18 am
Furthermore, the PDP Project proposal must now include information on “intellectual property, exclusivity contracts or commercial agreements, including details of any agreements or restrictions on licensing or 3rd-party access to the technology” (Annex CX, article 8, V). [read post]
4 Jun 2024, 3:15 am
For employees who do not live in these states, Lange v. [read post]
4 Jun 2024, 3:15 am
For employees who do not live in these states, Lange v. [read post]
5 Apr 2024, 6:05 am
” While the Second Circuit noted in its decision in U.S. v. [read post]
24 Mar 2024, 8:50 am
Though different in their details, these cases elucidate this issue from different perspectives:In January 2024, Rolex was successful in a US trade mark infringement case against BeckerTime before the United States Court of Appeals for the Fifth Circuit. [read post]
21 Mar 2024, 5:52 am
" State ex rel. [read post]
19 Mar 2024, 7:30 pm
The Court also set a licensing fee at US$ 0.008 per unit with an average licensing fee of around US$ 0.0013 per unit for each patent. [read post]
13 Mar 2024, 4:00 am
For the most part these trade disputes have been with the United States before NAFTA and Canada-U.S. [read post]
5 Mar 2024, 9:27 pm
At issue legally is Title 17 of the United States Code. [read post]
16 Jan 2024, 2:22 am
As Lord Kitchin stated, Dr. [read post]
